Believers in long life and frugal people are focused on the micro-dosing of consumption devices

The popularity of GLP-1 agonists for weight loss and health benefits has led to a rise in microdosing practices, particularly in the U.S. This trend is fueled by social media and the belief that smaller doses can reduce side effects and costs. While some users report success in maintaining weight with microdosing, concerns about safety and efficacy persist, as there are no clinical studies supporting this method. Influencers and some doctors advocate for microdosing, but the lack of medical supervision raises risks. The FDA has warned about potential adverse effects from unregulated products, highlighting the need for caution in this emerging practice.